Association of CDKN2A overexpression with poor prognosis, radioresistance, and immunosuppression in colorectal cancer
In colorectal cancer (CRC), dysregulated cyclin-dependent kinase inhibitor 2A (CDKN2A) contributes to disease progression. This investigation sought to explore the link between CDKN2A expression and the effectiveness of radiotherapy in CRC, and to investigate the underlying mechanisms. Transcriptomic...